TRANSIL-HSA High-Throughput assay 384 well plate
384 well plate for the determination of protein binding on HSAconfiguration: 93 compounds1 reference/ 3 TRANSIL® - HSA concentrations per compound
NIMBUS Biotechnology GmbH
NIMBUS Biotechnology is a leading provider of high-throughput assays, based on the well-known proprietary TRANSIL® technology for assessing ADME related parameters and for the prediction of ADME behaviour right from the start of the project. The NIMBUS TRANSIL® platform is a patented bead based assay technology allowing for the biofunctionalization of solid supports and enabling the company to develop innovative cutting-edge assays for drug discovery processes. Our unique ADME profiling service, NIMBUS Screening (in vitro and in silico), supports selection decisions at all stages.
Browse Products by Field
NIMBUS Biotechnology is a leading provider of high-throughput assays, based on the well-known proprietary TRANSIL® technology for assessing ADME related parameters and for the prediction of ADME behaviour right from the start of the project. The NIMBUS TRANSIL® platform is a patented bead based assay technology allowing for the biofunctionalization of solid supports and enabling the company to develop innovative cutting-edge assays for drug discovery processes. Our unique ADME profiling service, NIMBUS Screening (in vitro and in silico), supports selection decisions at all stages.